118 related articles for article (PubMed ID: 11171546)
1. Gene targeting in hemostasis. tissue factor pathway inhibitor.
Chan JC
Front Biosci; 2001 Feb; 6():D216-21. PubMed ID: 11171546
[TBL] [Abstract][Full Text] [Related]
2. Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit.
Chan JC; Carmeliet P; Moons L; Rosen ED; Huang ZF; Broze GJ; Collen D; Castellino FJ
J Clin Invest; 1999 Feb; 103(4):475-82. PubMed ID: 10021455
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor gene disruption.
Broze GJ
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S89-92. PubMed ID: 9819035
[TBL] [Abstract][Full Text] [Related]
4. Gene targeting in hemostasis. Factor VII.
Chan JC
Front Biosci; 2001 Feb; 6():D98-D104. PubMed ID: 11171545
[TBL] [Abstract][Full Text] [Related]
5. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity.
Caplice NM; Mueske CS; Kleppe LS; Simari RD
Circulation; 1998 Sep; 98(11):1051-7. PubMed ID: 9736590
[TBL] [Abstract][Full Text] [Related]
6. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
Zitoun D; Bara L; Basdevant A; Samama MM
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor-dependent pathway in severe preeclampsia revisited: a Brazilian cohort study.
Dusse LM; Godoi LC; Gomes KB; Carvalho Md; Lwaleed BA
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):436-40. PubMed ID: 26765308
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.
Huang ZF; Higuchi D; Lasky N; Broze GJ
Blood; 1997 Aug; 90(3):944-51. PubMed ID: 9242522
[TBL] [Abstract][Full Text] [Related]
9. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K
J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162
[TBL] [Abstract][Full Text] [Related]
10. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
[TBL] [Abstract][Full Text] [Related]
11. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels.
Crawley J; Lupu F; Westmuckett AD; Severs NJ; Kakkar VV; Lupu C
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1362-73. PubMed ID: 10807755
[TBL] [Abstract][Full Text] [Related]
12. Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor.
Johnson K; Zaror I; Bauer D; Choi Y; Creasey A; Innis M
Thromb Haemost; 1998 Oct; 80(4):585-7. PubMed ID: 9798974
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor.
Petersen LC; Bjørn SE; Olsen OH; Nordfang O; Norris F; Norris K
Eur J Biochem; 1996 Jan; 235(1-2):310-6. PubMed ID: 8631347
[TBL] [Abstract][Full Text] [Related]
14. Mutations of TFPI-binding exosites on factor VII cause bleeding phenotypes in factor VII deficiency.
Seanoon K; Payongsri P; Vivithanaporn P; Sirachainan N; Chuansumrit A; Hongeng S; Tanratana P
Blood Adv; 2022 Nov; 6(22):5887-5897. PubMed ID: 35973191
[TBL] [Abstract][Full Text] [Related]
15. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
[TBL] [Abstract][Full Text] [Related]
16. Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men.
Hansen JB; Grimsgaard S; Huseby N; Sandset PM; Bønaa KH
Thromb Res; 2001 Apr; 102(1):3-13. PubMed ID: 11323009
[TBL] [Abstract][Full Text] [Related]
17. The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.
Warshawsky I; Bu G; Mast A; Saffitz JE; Broze GJ; Schwartz AL
J Clin Invest; 1995 Apr; 95(4):1773-81. PubMed ID: 7706485
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays.
Kasthuri RS; Glover SL; Boles J; Mackman N
Semin Thromb Hemost; 2010 Oct; 36(7):764-71. PubMed ID: 20978997
[TBL] [Abstract][Full Text] [Related]
19. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice.
Pedersen B; Holscher T; Sato Y; Pawlinski R; Mackman N
Blood; 2005 Apr; 105(7):2777-82. PubMed ID: 15598816
[TBL] [Abstract][Full Text] [Related]
20. Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s).
Furlan Freguia C; Toso R; Pollak ES; Arruda VR; Pinotti M; Bernardi F
Haematologica; 2004 Dec; 89(12):1504-9. PubMed ID: 15590402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
